Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Yuzheng Pharmaceutical is a Chinese pharmaceutical company based in Harbin that specializes in the development and manufacturing of chemical drugs and traditional Chinese medicines (TCM). The company operates a large-scale production base in the Limin Development Zone, featuring multiple GMP-certified lines for tablets, capsules, and granules. Its commercial portfolio is heavily focused on over-the-counter (OTC) products, most notably its widely recognized treatments for the common cold and influenza. Beyond respiratory health, the company produces medications for cardiovascular diseases, digestive disorders, and nutritional supplementation. Yuzheng Pharmaceutical serves as a key regional player in the Northeast China pharmaceutical market, emphasizing high-volume production and domestic distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Yuzheng Pharmaceutical.